Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Emslie

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Sleep Medicine|February 9, 2010
Sleep and body mass index in depressed children and healthy controlsJulita Wojnar, Kirk J Brower, Richard Dopp, et al.
Psychiatry Research|August 7, 2017
Adolescent insomnia, suicide risk, and the interpersonal theory of suicideLucas Zullo, Sarah Horton, Michael Eaddy, et al.
Journal of Child and Adolescent Psychopharmacology|June 24, 2014
A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescentsMelissa P DelBello, Thomas J Hochadel, Kimberly Blanchard Portland, et al.
Iscience|April 23, 2025
Peripheral biological correlates of suicidality in children and adolescents: A systematic review and meta-analysisThomas K Pak, Emine Rabia Ayvaci, Thomas Carmody, et al.
Journal of Child and Adolescent Psychopharmacology|July 26, 2003
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?Daniel A Geller, Joseph Biederman, S Evelyn Stewart, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?Christopher J Kratochvil, Benedetto Vitiello, John Walkup, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2004
Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trialDaniel A Geller, Karen Dineen Wagner, Graham Emslie, et al.
Journal of Consulting and Clinical Psychology|June 3, 2009
Sources of site differences in the efficacy of a multisite clinical trial: the Treatment of SSRI-Resistant Depression in AdolescentsAnthony Spirito, Kaleab Z Abebe, Satish Iyengar, et al.
Pediatrics|June 3, 2006
Pharmacologic management of insomnia in children and adolescents: consensus statementJodi A Mindell, Graham Emslie, Jeffrey Blumer, et al.
Journal of Affective Disorders|December 31, 2022
Characterizing inflammatory profiles of suicidal behavior in adolescents: Rationale and designCherise Chin Fatt, Emine Rabia Ayvaci, Manish K Jha, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Sleep Medicine|February 9, 2010
Sleep and body mass index in depressed children and healthy controlsJulita Wojnar, Kirk J Brower, Richard Dopp, et al.
Psychiatry Research|August 7, 2017
Adolescent insomnia, suicide risk, and the interpersonal theory of suicideLucas Zullo, Sarah Horton, Michael Eaddy, et al.
Journal of Child and Adolescent Psychopharmacology|June 24, 2014
A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescentsMelissa P DelBello, Thomas J Hochadel, Kimberly Blanchard Portland, et al.
Iscience|April 23, 2025
Peripheral biological correlates of suicidality in children and adolescents: A systematic review and meta-analysisThomas K Pak, Emine Rabia Ayvaci, Thomas Carmody, et al.
Journal of Child and Adolescent Psychopharmacology|July 26, 2003
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?Daniel A Geller, Joseph Biederman, S Evelyn Stewart, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?Christopher J Kratochvil, Benedetto Vitiello, John Walkup, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2004
Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trialDaniel A Geller, Karen Dineen Wagner, Graham Emslie, et al.
Journal of Consulting and Clinical Psychology|June 3, 2009
Sources of site differences in the efficacy of a multisite clinical trial: the Treatment of SSRI-Resistant Depression in AdolescentsAnthony Spirito, Kaleab Z Abebe, Satish Iyengar, et al.
Pediatrics|June 3, 2006
Pharmacologic management of insomnia in children and adolescents: consensus statementJodi A Mindell, Graham Emslie, Jeffrey Blumer, et al.
Journal of Affective Disorders|December 31, 2022
Characterizing inflammatory profiles of suicidal behavior in adolescents: Rationale and designCherise Chin Fatt, Emine Rabia Ayvaci, Manish K Jha, et al.
Pageof 7